The global human microbiome market is expected to expand sharply over the next decade, according to a new industry outlook from SNS Insider. The report says the market was valued at USD 1.39 billion in 2025 and is projected to reach USD 7.66 billion by 2035, reflecting strong long-term growth for microbiome-related products and research.
The forecast points to rising interest in microbiome therapeutics and the broader use of precision medicine as key factors supporting the market. As researchers continue to study how microorganisms affect human health, companies and healthcare groups are increasing attention on treatments and technologies built around the microbiome.
In the United States, the market is projected to grow from USD 0.51 billion in 2025 to USD 1.94 billion by 2035. Europe is also expected to see major expansion, climbing from USD 0.38 billion to USD 1.94 billion over the same period. These regional gains suggest strong momentum in both established healthcare markets as microbiome science moves further into clinical and commercial development.
Overall, the outlook highlights a fast-evolving segment of the health industry, where research progress and personalized treatment strategies are helping shape future demand. With investment and scientific focus continuing to build, the human microbiome market is positioned for substantial growth through 2035.
